Short answer

Yes. And the reason matters more than the fact.

Most repeat STIs are reinfections (new exposures or untreated partners), not treatment failures.

Herpes and HPV “returns” reflect latency and persistence biology, not failed therapy. True drug resistance is the rare exception.

Each mechanism has a different fix, which is why repeat episodes need timeline audits rather than repeat prescriptions.

Advertisement

Sponsored: confidential STD testing with results in 1–2 days

Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.

See Tests & Prices →

The four recurrence mechanisms

1. Reinfection (most common)

Sex before treatment finished, partners who were never treated, or new exposures after cure.

The original treatment worked; a new transmission restarted disease.

Telltale signs: symptoms return weeks after documented clearance, partner treatment history has gaps, or new partners entered the picture.

Fix: retreat plus rigorous partner-network treatment. See Preventing STI Reinfection After Treatment.

2. Reactivation (herpes, HPV)

Herpes outbreaks recur from latency; HPV redetection reflects persistence or reactivation, not new infection.

These aren’t failures either. They’re the known biology of lifelong viruses, managed with suppressive therapy and monitoring rather than repeated cure attempts.

3. Persistence (unsuppressed HIV/HBV, untreated trichomoniasis)

Ongoing replication because therapy was never completed, was interrupted, or never started.

Fix: re-engage care, complete therapy, verify with follow-up testing.

4. True resistance (rare)

Adherence-verified, re-exposure-free persistence with susceptibility shifts. Notably gonorrhea and Mycoplasma genitalium.

Fix: cultures, resistance testing, alternative regimens, specialist referral, surveillance reporting.

How clinicians tell them apart

Exposure and partner timelines since therapy, adherence verification (missed doses, vomiting, interactions), organism genotyping where available, and susceptibility testing.

Most cases resolve to reinfection on history alone. Which is good news, because reinfection is fixable with network repair rather than regimen escalation.

Breaking the cycle

Simultaneous partner therapy for every episode, abstinence through clearance windows, 3-month retesting after bacterial STIs, exposure reduction going forward, and suppressive therapy where applicable (herpes).

Repeat infections are a systems problem with a systems solution.

When to seek care

At every repeat episode (bring full exposure and partner timelines. They are the diagnostic tool), for resistance workups when adherence-verified persistence occurs, and for prevention-plan overhauls when cycles repeat.